newsfilter
← Latest News
CNBC·

Johnson & Johnson to buy Momenta for about $6.5 billion

Johnson & Johnson said on Wednesday it would buy Momenta Pharmaceuticals for about $6.5 billion in cash to expand into the area of autoimmune disease treatments.